Tag: water desalination equipment industry share

Uncover key drivers, emerging technologies, and competitive movements shaping the point-of-care glucose testing market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Point-of-Care Glucose Testing Market show for the 2026–2030 period?

The market for point-of-care glucose testing has demonstrated significant growth over the past few years. It is forecast to expand from $5.14 billion in 2025 to $5.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.8%. This growth observed in prior periods can be attributed to the rising incidence of diabetes, increased engagement in self-monitoring practices, the widespread availability of cost-effective glucose meters, the broader provision of outpatient diabetes care, and an enhanced understanding of glycemic control.

The point-of-care glucose testing market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $6.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. This growth during the forecast period stems from factors such as the increasing uptake of connected glucose monitoring systems, greater integration with mobile health applications, a rising need for non-invasive monitoring solutions, the broadening of remote patient monitoring initiatives, and an intensifying emphasis on tailored diabetes management. Key trends expected over the forecast period encompass the wider adoption of Bluetooth-enabled glucose meters, the increasing utilization of continuous glucose monitoring devices, a rising preference for glucose testing performed at home, the expansion of digital platforms for diabetes management, and an amplified focus on patients monitoring themselves.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

What Drivers Are Shaping The Development Of The Point-of-Care Glucose Testing Market?

The increasing occurrence of diabetes is anticipated to propel the expansion of the point-of-care glucose testing market moving forward. Diabetes is a chronic metabolic condition that elevates blood glucose levels, potentially leading over time to severe damage in the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing is a frequently employed technology for determining glucose levels in hospitalized patients, aiding in prompt treatment decisions in response to glycemia changes, and enhancing therapeutic outcomes and diabetes management. For instance, in June 2024, according to the National Health Service (NHS England), a UK-based publicly funded healthcare system, in 2023, the number of individuals identified by the NHS in England as having pre-diabetes rose to 3,615,330, indicating an 18% increase from 3,065,825 in 2022. Additionally, among those under 40, cases surged nearly 25%, growing from 173,166 in 2022 to 216,440 in 2023. Therefore, the growing prevalence of diabetes is driving the growth of the point-of-care glucose testing market.

What Segment Types Are Examined In The Point-of-Care Glucose Testing Market?

The point-of-care glucose testing market covered in this report is segmented –

1) By Product: Lancet And Lancing Devices, Strips, Meters

2) By Testing Site: Fingertips, Alternate Site Testing

3) By Applications: Type-1 Diabetes, Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices

2) By Strips: Glucose Test Strips, Ketone Test Strips, Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

How Are Emerging Trends Affecting The Progression Of The Point-of-Care Glucose Testing Market?

Within the point-of-care glucose testing market, leading companies are concentrating on creating sophisticated technological solutions, notably wearable continuous glucose monitoring (CGM) systems incorporating predictive analytics. These innovations aim to bolster real-time glucose surveillance, optimize glycemic management, and alleviate the necessity for frequent manual testing. Such CGM systems operate via a compact sensor placed beneath the skin, which constantly records interstitial glucose readings and transmits this information to a mobile application, facilitating proactive health management through instant alerts and forecasts of glucose trends. An illustrative example is the launch of the Accu-Chek SmartGuide CGM system by Roche, a diagnostics company based in Switzerland, in July 2024, specifically developed for individuals with diabetes. This device delivers live glucose measurements every five minutes, incorporates AI-driven trend forecasting for up to two hours in advance, provides nocturnal warnings for low or high blood sugar, and links effortlessly to a mobile app for comprehensive data monitoring and remote health supervision, thereby significantly improving safety and user convenience when contrasted with conventional finger-prick glucose devices.

Who Are The Top-Performing Companies In The Point-of-Care Glucose Testing Market In Recent Years?

Major companies operating in the point-of-care glucose testing market are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Siemens Healthineers, TaiDoc Technology Corporation, Nipro Corporation, Dexcom Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., Medtronic plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Which Region Currently Holds The Largest Share Of The Point-of-Care Glucose Testing Market?

North America was the largest region in the point-of-care glucose testing market in 2025. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Point-of-Care Glucose Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

Browse Through More Reports Similar to the Global Point-of-Care Glucose Testing Market 2026, By The Business Research Company

Blood Glucose Monitoring Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-monitoring-systems-global-market-report

Blood Glucose Meters Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Continous Blood Glucose Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/continous-blood-glucose-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the point-of-care glucose testing market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Point-of-Care Glucose Testing Market show for the 2026–2030 period?

The market for point-of-care glucose testing has demonstrated significant growth over the past few years. It is forecast to expand from $5.14 billion in 2025 to $5.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.8%. This growth observed in prior periods can be attributed to the rising incidence of diabetes, increased engagement in self-monitoring practices, the widespread availability of cost-effective glucose meters, the broader provision of outpatient diabetes care, and an enhanced understanding of glycemic control.

The point-of-care glucose testing market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $6.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. This growth during the forecast period stems from factors such as the increasing uptake of connected glucose monitoring systems, greater integration with mobile health applications, a rising need for non-invasive monitoring solutions, the broadening of remote patient monitoring initiatives, and an intensifying emphasis on tailored diabetes management. Key trends expected over the forecast period encompass the wider adoption of Bluetooth-enabled glucose meters, the increasing utilization of continuous glucose monitoring devices, a rising preference for glucose testing performed at home, the expansion of digital platforms for diabetes management, and an amplified focus on patients monitoring themselves.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

What Drivers Are Shaping The Development Of The Point-of-Care Glucose Testing Market?

The increasing occurrence of diabetes is anticipated to propel the expansion of the point-of-care glucose testing market moving forward. Diabetes is a chronic metabolic condition that elevates blood glucose levels, potentially leading over time to severe damage in the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing is a frequently employed technology for determining glucose levels in hospitalized patients, aiding in prompt treatment decisions in response to glycemia changes, and enhancing therapeutic outcomes and diabetes management. For instance, in June 2024, according to the National Health Service (NHS England), a UK-based publicly funded healthcare system, in 2023, the number of individuals identified by the NHS in England as having pre-diabetes rose to 3,615,330, indicating an 18% increase from 3,065,825 in 2022. Additionally, among those under 40, cases surged nearly 25%, growing from 173,166 in 2022 to 216,440 in 2023. Therefore, the growing prevalence of diabetes is driving the growth of the point-of-care glucose testing market.

What Segment Types Are Examined In The Point-of-Care Glucose Testing Market?

The point-of-care glucose testing market covered in this report is segmented –

1) By Product: Lancet And Lancing Devices, Strips, Meters

2) By Testing Site: Fingertips, Alternate Site Testing

3) By Applications: Type-1 Diabetes, Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices

2) By Strips: Glucose Test Strips, Ketone Test Strips, Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

How Are Emerging Trends Affecting The Progression Of The Point-of-Care Glucose Testing Market?

Within the point-of-care glucose testing market, leading companies are concentrating on creating sophisticated technological solutions, notably wearable continuous glucose monitoring (CGM) systems incorporating predictive analytics. These innovations aim to bolster real-time glucose surveillance, optimize glycemic management, and alleviate the necessity for frequent manual testing. Such CGM systems operate via a compact sensor placed beneath the skin, which constantly records interstitial glucose readings and transmits this information to a mobile application, facilitating proactive health management through instant alerts and forecasts of glucose trends. An illustrative example is the launch of the Accu-Chek SmartGuide CGM system by Roche, a diagnostics company based in Switzerland, in July 2024, specifically developed for individuals with diabetes. This device delivers live glucose measurements every five minutes, incorporates AI-driven trend forecasting for up to two hours in advance, provides nocturnal warnings for low or high blood sugar, and links effortlessly to a mobile app for comprehensive data monitoring and remote health supervision, thereby significantly improving safety and user convenience when contrasted with conventional finger-prick glucose devices.

Who Are The Top-Performing Companies In The Point-of-Care Glucose Testing Market In Recent Years?

Major companies operating in the point-of-care glucose testing market are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Siemens Healthineers, TaiDoc Technology Corporation, Nipro Corporation, Dexcom Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., Medtronic plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Which Region Currently Holds The Largest Share Of The Point-of-Care Glucose Testing Market?

North America was the largest region in the point-of-care glucose testing market in 2025. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Point-of-Care Glucose Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

Browse Through More Reports Similar to the Global Point-of-Care Glucose Testing Market 2026, By The Business Research Company

Blood Glucose Monitoring Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-monitoring-systems-global-market-report

Blood Glucose Meters Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Continous Blood Glucose Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/continous-blood-glucose-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Point-of-Care Glucose Testing Market?

In recent times, the market size of point-of-care glucose testing has seen stable growth. It is projected to escalate from a value of $4.91 billion in 2024 and reach $5.14 billion in 2025, endorsing a compound annual growth rate (CAGR) of 4.7%. The historic growth has been driven by factors such as the amplified occurrence of diabetes, heightened consciousness about diabetes control, the growth of the geriatric population, improvements in healthcare infrastructure, and the acceptance of point-of-care testing.

In the upcoming years, a significant surge is anticipated in the size of the point-of-care glucose testing market. The market is predicted to hit $6.5 billion in 2029, progressing at a compound annual growth rate (CAGR) of 6.0%. Factors propelling growth during this predicted period include the proliferation of telemedicine services, a heightened focus on personalized diabetes care, an increase in diabetes management initiatives, greater investment into glucose testing research and development, and the adoption of continuous glucose monitoring. Key trends to watch in this period include the advent of wearable glucose monitoring devices, the incorporation of smartphone connectivity in glucose testing, the rise of point-of-care testing in home healthcare environments, the use of artificial intelligence for analyzing glucose data, and the advancement of remote patient monitoring for diabetes.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

What Underlying Factors Are Supporting The Point-of-Care Glucose Testing Market Growth?

The escalating rates of diabetes are set to drive the expansion of the point-of-care glucose testing market. As a chronic metabolic disorder, diabetes causes an increase in blood glucose levels that can result in significant harm to the heart, blood vessels, eyes, kidneys, and nerves over time. Point-of-care glucose testing is a commonly utilized tool for monitoring glucose levels in hospitalized patients, aiding the quick making of treatment plans according to glycemia fluctuations and improving both the treatment outcome and the management of diabetes. For example, the National Health Service (NHS England), a funded healthcare system based in the UK, reported in June 2024 that the number of individuals identified as pre-diabetic by the NHS in England in 2023 had risen to 3,615,330, a growth of 18% from the 2022 figure of 3,065,825. Furthermore, there was a near 25% surge in cases among those below 40, climbing from 173,166 in 2022 to 216,440 in 2023. Hence, the rising prevalence of diabetes is propelling the expansion of the point-of-care glucose testing market.

How Does The Point-of-Care Glucose Testing Market Differ By Segment?

The point-of-care glucose testingmarket covered in this report is segmented –

1) By Product: Lancet And Lancing Devices; Strips; Meters

2) By Testing Site: Fingertips; Alternate Site Testing

3) By Applications: Type-1 Diabetes; Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers; Hospitals And Clinics; Home Care Settings; Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets; Multi-Use Lancets; Adjustable Lancing Devices

2) By Strips: Glucose Test Strips; Ketone Test Strips; Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters; Continuous Glucose Monitoring (CGM) Meters; Bluetooth-Enabled Meters

What New Opportunities Are Emerging From Trends In The Point-of-Care Glucose Testing Market?

The rising trend in the point-of-care glucose testing market is driven by product innovation. Leading companies in this market are strategizing on the introduction of inventive products to consolidate their market standing. For example, in January 2022, F. Hoffmann-La Roche AG, a health services company based in Switzerland, rolled out Cobas Pulse – it’s a new point-of-care blood glucose monitoring gadget for healthcare professionals. This device operates like a touchscreen smartphone, running its customized applications. The Cobas Pulse is a portable device equipped with an automated glucose test strip reader, a camera, and a touchscreen that provides diagnostic data recording. It comes in a sturdy, disinfectable casing and can be used across all patient age types, including newborns and intensive care patients. Furthermore, it is designed to enhance physicians’ workflow by executing the Glucommander dosage software on the blood glucose monitor and integrating downloadable decision-support apps from companies like Smart4Diagnostics, CardioSignal, and SteadySense.

Who Are The Global Leaders Steering The Point-of-Care Glucose Testing Market Forward?

Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Point-of-Care Glucose Testing Market?

North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

Browse Through More Reports Similar to the Global Point-of-Care Glucose Testing Market 2025, By The Business Research Company

Spray Drying Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/spray-drying-equipment-global-market-report

Antidepressant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report

Antiemetics And Antinauseants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Point-of-Care Glucose Testing Industry Expected To Reach By 2029, Starting From 2025 Levels?

The market for point-of-care glucose testing has experienced consistent expansion over the last few years. This market is projected to expand, increasing from $4.91 billion in 2024 to reach $5.14 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 4.7%. Historically, this growth can be ascribed to several factors, including the increasing occurrence of diabetes, heightened understanding of diabetes management, the expanding elderly demographic, advancements in healthcare infrastructure, and the uptake of point-of-care testing methods.

The point-of-care glucose testing market size is expected to experience robust growth in the upcoming years. It is projected to expand to $6.5 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.0%. The anticipated growth during this period can be attributed to factors such as the expansion of telemedicine services, an increased emphasis on personalized medicine in diabetes care, a rise in diabetes management programs, augmented investment in glucose testing research and development, and the adoption of continuous glucose monitoring. Significant trends for the forecast period include the development of wearable glucose monitoring devices, the integration of smartphone connectivity in glucose testing, the expansion of point-of-care testing into home healthcare settings, the utilization of artificial intelligence for glucose data analysis, and the broadened scope of remote patient monitoring for diabetes.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

Which Factors And Drivers Are Influencing The Point-of-Care Glucose Testing Market In 2025?

The increasing prevalence of diabetes is projected to fuel the expansion of the point-of-care glucose testing market moving forward. Diabetes, a chronic metabolic disorder, causes elevated blood glucose levels, which can progressively lead to severe damage to the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing represents a widely utilized method for assessing glucose levels in hospitalized patients, enabling swift treatment decisions in response to changes in glycemia, thereby improving therapeutic outcomes and diabetes management. For instance, in June 2024, according to The National Health Service (NHS England), a UK-based publicly funded healthcare system, the number of individuals identified by the NHS in England as having pre-diabetes reached 3,615,330 in 2023, signifying an 18% rise from 3,065,825 in 2022. Furthermore, among those under 40, cases escalated by nearly 25%, increasing from 173,166 in 2022 to 216,440 in 2023. Consequently, the rising incidence of diabetes is propelling the growth of the point-of-care glucose testing market.

What Are The Major Segments Identified In The Point-of-Care Glucose Testing Market?

The point-of-care glucose testingmarket covered in this report is segmented –

1) By Product: Lancet And Lancing Devices; Strips; Meters

2) By Testing Site: Fingertips; Alternate Site Testing

3) By Applications: Type-1 Diabetes; Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers; Hospitals And Clinics; Home Care Settings; Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets; Multi-Use Lancets; Adjustable Lancing Devices

2) By Strips: Glucose Test Strips; Ketone Test Strips; Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters; Continuous Glucose Monitoring (CGM) Meters; Bluetooth-Enabled Meters

How Are Emerging Market Trends Shaping The Point-of-Care Glucose Testing Industry Landscape?

Product innovation represents a primary trend gaining traction in the point-of-care glucose testing market. Major companies operating within the point-of-care glucose testing market are dedicated to developing novel products to bolster their market position. For example, in January 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, introduced Cobas Pulse, a new point-of-care blood glucose monitor specifically for healthcare staff. This monitor will come with a companion device styled like a touchscreen smartphone, which runs its associated applications. Cobas Pulse is a handheld unit equipped with an automated glucose test strip reader, a camera, and a touchscreen, allowing for the documentation of diagnostic data. It is housed in a robust, disinfectable casing, making it suitable for use with patients of all age groups, including newborns and those in intensive care. Additionally, it seeks to optimize physicians’ workflow by running the Glucommander dosage software directly on the blood glucose reader and by facilitating the addition of downloadable decision-support apps from firms such as Smart4Diagnostics, CardioSignal, and SteadySense.

Which Key Players Are Driving Competition In The Point-of-Care Glucose Testing Market?

Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Which Regional Markets Are Contributing Most To The Point-of-Care Glucose Testing Industry Expansion?

North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Point-of-Care Glucose Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

Browse Through More Reports Similar to the Global Point-of-Care Glucose Testing Market 2025, By The Business Research Company

Spray Drying Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/spray-drying-equipment-global-market-report

Antidepressant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report

Antiemetics And Antinauseants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Point-of-Care Glucose Testing Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, the market size for point-of-care glucose testing has been on a consistent rise. It’s expected to increase from $4.91 billion in 2024 to $5.14 billion in 2025 with a compound annual growth rate (CAGR) of 4.7%. The historic period’s growth is due to various factors like increased incidences of diabetes, better awareness about diabetes management, growth of the elderly population, improvement in healthcare infrastructure, and the adoption of point-of-care testing.

The market size for point-of-care glucose testing is forecasted to experience significant expansion in the upcoming years, expected to reach $6.5 billion by 2029 with a compound annual growth rate (CAGR) of 6.0%. The projected growth during this period is ascribed to the broadening of telemedicine services, heightened focus on personalized medicine for diabetes care, increase in diabetes management initiatives, heightened funding towards glucose testing R&D, and the uptake of continuous glucose monitoring. Key trends for this forecast period encompass the emergence of wearable glucose monitoring devices, integration of smartphone connectivity for glucose testing, the expansion of point-of-care testing within home healthcare contexts, utilization of artificial intelligence for glucose data analysis, and the proliferation of remote patient monitoring for diabetes.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

Which Factors and External Forces Are Driving Demand in the Point-of-Care Glucose Testing Market?

The rising instances of diabetes are anticipated to stimulate the expansion of the point-of-care glucose testing market. As a persistent metabolic disorder, diabetes results in increased blood glucose levels which can gradually lead to severe harm to the heart, blood vessels, eyes, kidneys, and nerves over time. Point-of-care glucose testing is a common technique used to estimate sugar levels in hospitalized patients, allowing for swift treatment modifications in reaction to blood sugar variations, and boosting therapeutic effects and diabetes control. For instance, The National Health Service (NHS England), a publicly subsidized healthcare system in the UK, reported in June 2024 that the number of individuals identified as having pre-diabetes in England rose to 3,615,330 in 2023, an 18% increase from 3,065,825 in 2022. Furthermore, a nearly 25% surge was noted in those below 40, with figures rising from 173,166 in 2022 to 216,440 in 2023. Thus, the escalating prevalence of diabetes is fueling the expansion of the point-of-care glucose testing market.

Which Segments in the Point-of-Care Glucose Testing Offer the Most Growth?

The point-of-care glucose testingmarket covered in this report is segmented –

1) By Product: Lancet And Lancing Devices; Strips; Meters

2) By Testing Site: Fingertips; Alternate Site Testing

3) By Applications: Type-1 Diabetes; Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers; Hospitals And Clinics; Home Care Settings; Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets; Multi-Use Lancets; Adjustable Lancing Devices

2) By Strips: Glucose Test Strips; Ketone Test Strips; Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters; Continuous Glucose Monitoring (CGM) Meters; Bluetooth-Enabled Meters

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Point-of-Care Glucose Testing Market?# Market?

North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive thePoint-of-Care Glucose Testing Market’s Growth?

The main trend emerging in the point-of-care glucose testing market is product innovation. Primary players in the market are concentrating on creating novel products to bolster their market stance. An illustration of this is F. Hoffmann-La Roche AG, a healthcare firm based in Switzerland, which launched Cobas Pulse, a novel point-of-care blood glucose monitor for medical professionals in January 2022. It is complemented by a device that resembles a touchscreen smartphone and hosts its applications. The Cobas Pulse is a portable device featuring an automated glucose test strip reader, a camera, and a touchscreen. It allows for recording diagnostic data and is encased in a sturdy exterior which can be sterilized and used for patients across all age groups, including newborns and those in intensive care. Furthermore, it aims to enhance doctors’ workflow by employing the Glucommander dosage software on the blood glucose reader, and integrating decision-support applications from firms such as Smart4Diagnostics, CardioSignal, and SteadySense that can be downloaded.

View the full report here:

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

What Are the Key Elements That Define the Point-of-Care Glucose Testing Market?

Point-of-care glucose testing is referred to as a quality-assured pathology service delivered close to the patient rather than in the usual setting of a clinical laboratory. It is used for glucose testing by clinicians or individuals using small handheld units or glucose analyzers that use testing strips to analyze whole blood, thereby reducing the time from specimen collection to result in verification and translating to faster therapeutic intervention, reduced preanalytical errors, and improved patient care.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12207

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Point-of-Care Glucose Testing Market Grown from 2024 to 2025?

In past years, the point-of-care glucose testing market has experienced a consistent growth. From 2024 to 2025, it is predicted to increase from $4.91 billion to $5.15 billion, exhibiting a compound annual growth rate (CAGR) of 4.9%. Reasons for the historic growth include an increasing number of diabetes cases, rising awareness related to managing diabetes, growth of the aging population, improvements in healthcare infrastructures, and a higher uptake of point-of-care testing.

What Growth Rate Is Anticipated for the Point-of-Care Glucose Testing Market in the Coming Years?

Anticipations forecast a considerable upsurge in the market size of point-of-care glucose testing in the upcoming years. With a projected compound annual growth rate (CAGR) of 6.0%, the market value will reach $6.51 billion by 2029. The surge during the forecast period is likely due to the broadening scope of telemedicine services, an increased focus on tailored medicine for diabetes treatment, the proliferation of diabetes management programs, amplified funding in glucose testing R&D, and the embracement of continuous glucose monitoring. Key trends for the projected period incorporate the evolution of wearable glucose monitoring apparatus, the merger of smartphone connectivity with glucose testing, the proliferation of point-of-care testing in domestic health care environments, the incorporation of artificial intelligence in analyzing glucose data, and the enlargement of remote patient monitoring for diabetes.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

Who Are the Leading Companies in the Point-of-Care Glucose Testing Market?

Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

What Are the Key Drivers of the Point-of-Care Glucose Testing Market?

The escalation in diabetes prevalence is projected to fuel the expansion of the point-of-care glucose testing market in the near future. Defined as a chronic metabolic anomaly, Diabetes results in heightened blood glucose levels, which, over periods of time, can eventually cause severe harm to the heart, blood vessels, eyes, kidneys, and nerves. Widely in use among hospitalized patients, the point-of-care glucose testing technology enables immediate treatment decisions regarding changes in glycemia, thereby optimizing therapeutic efficacy and managing diabetes more effectively. As an example, The National Health Service (NHS England), a UK-based public health service provider, reported in June 2024 that the number of individuals identified as having pre-diabetes escalated to 3,615,330 in 2023; representing a rise of 18% from 3,065,825 in 2022. Furthermore, the cases among those under 40 soared by nearly 25%, growing from 173,166 in 2022 to 216,440 in 2023. Consequently, the rising prevalence of diabetes is contributing to the advancement of the point-of-care glucose testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

What Are the Key Market Segments in the Point-of-Care Glucose Testing Industry?

The point-of-care glucose testing market covered in this report is segmented –

1) By Product: Lancet And Lancing Devices, Strips, Meters

2) By Testing Site: Fingertips, Alternate Site Testing

3) By Applications: Type-1 Diabetes, Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices

2) By Strips: Glucose Test Strips, Ketone Test Strips, Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

What Are the Latest Trends in the Point-of-Care Glucose Testing Market?

In the point-of-care glucose testing market, the predominant trend that is emerging is product innovation. With an aim to solidify their market standing, major companies in this sector are channeling their efforts towards the creation of ground-breaking products. An example of this is the launch of Cobas Pulse by F. Hoffmann-La Roche AG, a Swiss healthcare company, in January 2022. Catering to healthcare professionals, this new point-of-care blood glucose monitor resembles a touchscreen smartphone in design and runs various applications. Cobas Pulse features a handheld, rugged design, an automated glucose test strip reader, a camera, and a touchscreen, which can be disinfected after usage and is suitable for patients across age groups, including newborns and those in intensive care. It is designed to streamline the workflows of physicians by integrating the Glucommander dosage software into the blood glucose reader, and providing access to decision-support applications from companies like Smart4Diagnostics, CardioSignal, and SteadySense.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

What Are the Key Regional Markets in the Point-of-Care Glucose Testing Industry?

North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12207

This Report Delivers Insight On:

1. How big is the point-of-care glucose testing market, and how is it changing globally?

2. Who are the major companies in the point-of-care glucose testing market, and how are they performing?

3. What are the key opportunities and risks in the point-of-care glucose testing market right now?

4. Which products or customer segments are growing the most in the point-of-care glucose testing market?

5. What factors are helping or slowing down the growth of the point-of-care glucose testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of thePoint-of-Care Glucose Testing Market?

The point-of-care glucose testing market is predicted to expand due to the increasing instances of diabetes. This chronic metabolic affliction elevates blood sugar levels, culminating over the years in severe harm to the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing is an often utilized method for determining glucose levels in hospitalized patients. It expedites treatment decisions in response to glucose level variations, increasing the effectiveness of treatment and the management of diabetes. For instance, The National Health Service (NHS England), a UK public healthcare entity, reported in June 2024 that the individuals recognized by NHS in England as pre-diabetic had increased to 3,615,330 in 2023 – an 18% jump from 3,065,825 in 2022. Furthermore, there was a roughly 25% increase in cases among individuals below 40, escalating from 173,166 in 2022 to 216,440 in 2023. Therefore, the mounting prevalence of diabetes is fueling the growth of the point-of-care glucose testing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

How Will the Growth Rate of thePoint-of-Care Glucose Testing Market Impact Industry Trends by 2034?

The market size for point-of-care glucose testing has been consistently expanding over the recent years. A growth from $4.91 billion in 2024 to $5.15 billion in 2025 is anticipated, reflecting a compound annual growth rate (CAGR) of 4.9%. This growth, witnessed in the historical span, is fueled by factors like escalating diabetes prevalence, increased consciousness regarding diabetes management, a growing elderly population, expansion of healthcare infrastructure and widespread uptake of point-of-care testing.

The point-of-care glucose testing market is set for a robust expansion in the upcoming years, primed to reach $6.51 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. This growth trajectory for the forecast period can be traced back to factors like the rise of telemedicine, an increasing focus on individualized diabetes care, upswing in diabetes management programs, surge in investment for glucose testing research and development, and the adoption of continuous glucose monitoring. The forecasted period is also anticipated to observe trends such as the emergence of wearable glucose monitoring devices, the incorporation of smartphone capability into glucose testing, expanded use of point-of-care testing in domestic healthcare environments, application of artificial intelligence in analyzing glucose data and a broader implementation of remote patient scrutiny for diabetes.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12207

What Key Market Trends and Innovations Are Shaping the Future of thePoint-of-Care Glucose Testing Industry?

Product innovation is emerging as a prominent trend in the point-of-care glucose testing market, with key players aiming to introduce unique products to solidify their market stance. For instance, Switzerland-based healthcare giant F. Hoffmann-La Roche AG launched a new point-of-care blood glucose monitor named Cobas Pulse in January 2022, designed for healthcare workers. The device comes with a companion tool designed like a touchscreen smartphone which runs its own applications. The Cobas Pulse functions as a pocket-sized device with an automatic glucose test strip reader, camera, and touchscreen for recording diagnostic data. It features a durable case that can withstand disinfection, making it suitable for use with patients across various age groups, including newborns and those in intensive care. Moreover, it aims to streamline the workflow for medical practitioners by integrating Glucommander dosage software into the blood glucose reader. It also supports apps developed by companies like Smart4Diagnostics, CardioSignal, and SteadySense that can be downloaded for decision-making assistance.

Which Companies Are Leading the Charge in Expanding thePoint-of-Care Glucose Testing Market Growth?

Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

How is the Global Point-of-Care Glucose Testing Market Segemented?

The point-of-care glucose testing market covered in this report is segmented –

1) By Product: Lancet And Lancing Devices, Strips, Meters

2) By Testing Site: Fingertips, Alternate Site Testing

3) By Applications: Type-1 Diabetes, Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices

2) By Strips: Glucose Test Strips, Ketone Test Strips, Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

Which Geographics are Influencing the Growth of the Point-of-Care Glucose Testing Market?

North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Point-of-Care Glucose Testing Maret 2025, By The Business Research Company:

Spray Drying Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/spray-drying-equipment-global-market-report

Neurostimulation Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

Pharmaceutical Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the point-of-care glucose testing market grown in recent years?

The market size for point-of-care glucose testing has seen consistent growth over the years. It is projected to escalate from $4.91 billion in 2024 to $5.15 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 4.9%. Factors contributing to the growth in the past include a rise in diabetes occurrence, heightened awareness of diabetes control, expanding elderly population, improvements in healthcare infrastructure, and the adoption of point-of-care testing.

How is the point-of-care glucose testing market size expected to evolve during the forecast period?

In the coming years, significant expansion is projected for the point-of-care glucose testing market. By 2029, its size is anticipated to reach $6.51 billion, with a compound annual growth rate (CAGR) of 6.0%. The growth during the forecast period is largely due to broader telemedicine services, a heightened focus on personalized diabetes treatment, an increase in diabetes management initiatives, greater investment in glucose testing R&D, and widespread adoption of continuous glucose monitoring. Key trends for the forecast period include the rise of wearable glucose monitoring gadgets, the integration of smartphone connectivity in glucose testing devices, the expansion of point-of-care testing in home healthcare environments, the adoption of artificial intelligence for glucose data interpretation, and the broadening scope of remote patient monitoring specifically for diabetes.

Get your point-of-care glucose testing market report here!

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Which key drivers are propelling the point-of-care glucose testing market’s growth?

The increasing incidence of diabetes is anticipated to spur the expansion of the point-of-care glucose testing market in future. Diabetes is a persistent metabolic disease that raises blood sugar levels, causing extensive damage to the heart, blood vessels, eyes, kidneys, and nerves over a long period. Point-of-care glucose testing, a popular technology for measuring glucose levels in hospitalized patients, promotes rapid treatment plans following changes in glycemia, boosts therapeutic outcomes, and enhances diabetes control. For example, The National Health Service (NHS England), a UK-based state-funded healthcare system, reported in June 2024 that the number of people identified as pre-diabetic by the NHS in England escalated to 3,615,330 in 2023, showing an 18% growth from 3,065,825 in 2022. Moreover, there was an approximately 25% increase in cases among those below 40, rising from 173,166 in 2022 to 216,440 in 2023. Consequently, the escalating incidence of diabetes is fueling the expansion of the point-of-care glucose testing market.

What are the market segments in the point-of-care glucose testing industry?

The point-of-care glucose testing market covered in this report is segmented –

1) By Product: Lancet And Lancing Devices, Strips, Meters

2) By Testing Site: Fingertips, Alternate Site Testing

3) By Applications: Type-1 Diabetes, Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices

2) By Strips: Glucose Test Strips, Ketone Test Strips, Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

Which leading companies are shaping the growth of the point-of-care glucose testing market?

Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

What key trends are currently impacting the point-of-care glucose testing market’s development?

The emergence of product innovation is a notable trend in the point-of-care glucose testing market as leading corporations prioritize the creation of revolutionary products to strengthen their market presence. For example, in January 2022, F. Hoffmann-La Roche AG, a renowned healthcare firm based in Switzerland, unveiled Cobas Pulse, a state-of-the-art point-of-care blood glucose monitor designed for healthcare professionals. This device comes with a companion gadget that has the look and feel of a modern touchscreen smartphone, complete with its applications. Cobas Pulse, a handheld device, boasts features including auto glucose test strip reader, camera, and touchscreen. These allow for recording diagnostic data in a robust casing that can be sanitized and made suitable for patients of varying ages, from newborns to those in critical care. Aimed at enhancing doctors’ workflow, it combines the Glucommander dosage software with the glucose reader and offers downloadable decision-support applications from businesses such as Smart4Diagnostics, CardioSignal, and SteadySense.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12207

Which geographic areas are influencing the growth of the point-of-care glucose testing market?

North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Spray Drying Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/spray-drying-equipment-global-market-report

Neurostimulation Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

Pharmaceutical Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: